Skip to content
← Back to this collection

PUBLICATIONS · 25800893

Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2015 Apr
First author
Pui CH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Apr;16(4):362-4. doi: 10.1016/S1470-2045(15)70123-3.
    note
    Source null
    related pmid
    25800894
    relationship
    Comment in

Authors and identifiers

  1. name
    Pui CH
    type
    Author
  2. name
    Pei D
    type
    Author
  3. name
    Coustan-Smith E
    type
    Author
  4. name
    Jeha S
    type
    Author
  5. name
    Cheng C
    type
    Author
  6. name
    Bowman WP
    type
    Author
  7. name
    Sandlund JT
    type
    Author
  8. name
    Ribeiro RC
    type
    Author
  9. name
    Rubnitz JE
    type
    Author
  10. name
    Inaba H
    type
    Author
  11. name
    Bhojwani D
    type
    Author
  12. name
    Gruber TA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Pui CH
    type
    Author
  2. name
    Pei D
    type
    Author
  3. name
    Coustan-Smith E
    type
    Author
  4. name
    Jeha S
    type
    Author
  5. name
    Cheng C
    type
    Author
  6. name
    Bowman WP
    type
    Author
  7. name
    Sandlund JT
    type
    Author
  8. name
    Ribeiro RC
    type
    Author
  9. name
    Rubnitz JE
    type
    Author
  10. name
    Inaba H
    type
    Author
  11. name
    Bhojwani D
    type
    Author
  12. name
    Gruber TA
    type
    Author
bibliography ids
  1. nci-bib-1dbb14930dfe8d5735fb5de1
book metadata
content sha256
70bb80611ed32b834822efc473c6485356997e08c4fa4145410af4d4f6fd5380
document type
citation
dois
  1. 10.1016/S1470-2045(15)70082-3
electronic publication date
display
2015 Mar 20
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:25800893
immutable id
pubmed:25800893@70bb80611ed32b834822efc473c6485356997e08c4fa4145410af4d4f6fd5380
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
4
name
The Lancet. Oncology
nlm unique id
100957246
pages
465-74
volume
16
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Apr;16(4):362-4. doi: 10.1016/S1470-2045(15)70123-3.
    note
    Source null
    related pmid
    25800894
    relationship
    Comment in
outcomes validated
false
pmid
25800893
provenance
batch id
74265f1b641f04cf2d05
provider
NCBI PubMed ESummary
record sha256
c68071011becbff8a4b7d05a09cab755d018c24a02724f7b7003994d9c6fcc40
response sha256
193df6bb6d2ac41af73dc445bf8171fe8076a8c8a5e98882a3d6a1ada428b0f0
retrieved at
2026-09-09T23:47:10.134322+00:00
publication date
display
2015 Apr
precision
month
year
2015
publication types
  1. Clinical Trial
  2. Journal Article
  3. Research Support, N.I.H., Extramural
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25800893/
title
Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.

Preserved source evidence · Not medical advice